30 Day Trial

Alphatec Spine Announces Preliminary 3Q15 Revenue

Share:

Alphatec Spine announced preliminary 3Q15 revenue of ~US $43MM (U.S. ~$27.4MM, +0.5%;  ex-U.S. ~$15.6MM, +13% constant currency).

Speaking on stabilization of its U.S. business, company leadership highlighted an expansion of coverage in U.S. territories that historically lacked representation. An estimated $3MM in 4Q15 revenue is expected to arise from new U.S. markets. 

Detailed 3Q15 results will be announced on 11/3/15.

Source: Alphatec Spine, Inc.